Dr. Friend is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4525 Cameron Valley Pkwy
Ste 3500
Charlotte, NC 28211Phone+1 704-302-8300
Education & Training
- ECU Health Medical Center/East Carolina UniversityChief Residency, Internal Medicine, 2012
- Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2013 - 2016
- ECU Health Medical Center/East Carolina UniversityResidency, Internal Medicine, 2009 - 2012
- Ross University School of MedicineClass of 2009, MD
- George Washington UniversityBA, Liberal Arts, 1998 - 2002
- George Washington UniversityB. A., Liberal Arts, 1998 - 2002
Certifications & Licensure
- NC State Medical License 2009 - 2025
- VA State Medical License 2012 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma.Manisha Bhutani, Myra Robinson, David Foureau, Shebli Atrash, Barry A Paul
Blood Advances. 2024-11-22 - Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study).Hamid Ehsan, Myra Robinson, Peter M Voorhees, Kristen Cassetta, Shanice Borden
Life. 2024-03-14 - Fragile Warriors: Navigating the Delicate Dance of Frailty and CAR-T cell Therapy for Relapsed/Refractory Multiple Myeloma.Reed Friend, Shebli Atrash
Transplantation and Cellular Therapy. 2024-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: